Histopathological and clinical changes in patients with severe lupus nephritis treated with rituximab plus cyclophosphamide: A rebiopsy study in 7 patients

被引:0
|
作者
Gunnarsson, I.
Sundelin, B.
Jonsdottir, T.
Jacobsson, S. H.
Welin-Henriksson, E.
Van Vollenhoven, R. F.
机构
[1] Karolinska Univ Hosp, Stockholm, Sweden
[2] Danderyd Hosp, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:64 / 64
页数:1
相关论文
共 50 条
  • [31] Clinical and morphological correlations in patients with lupus nephritis: a retrospective study
    V. Kurginian, Kseniia
    Stoliarevich, Ekaterina S.
    Litvinova, Mariia A.
    Kokhanchuk, Valeria A.
    Shevchenko, Savely N.
    Pugach, Valeriia A.
    Novikov, Pavel I.
    V. Moiseev, Sergey
    Bulanov, Nikolay M.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (06) : 587 - 592
  • [32] Discoid lupus erythematosus in Iraqi patients: a clinical and histopathological study
    Al-Hattab, MK
    Al-Waiz, M
    ANNALS OF SAUDI MEDICINE, 2004, 24 (04) : 289 - 292
  • [33] Genetic polymorphisms effect on cyclophosphamide's tolerability and clinical efficacy in Egyptian patients with lupus nephritis
    Abuelsoud, Nermeen N.
    EL Khateeb, Engy M.
    PHARMACOGENETICS AND GENOMICS, 2023, 33 (08): : 172 - 180
  • [34] Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis
    Conlon, PJ
    Fischer, CA
    Levesque, MC
    Smith, SR
    StClair, EW
    Allen, NB
    Fleming, JA
    Howell, DN
    CLINICAL NEPHROLOGY, 1996, 46 (03) : 170 - 175
  • [35] HISTOPATHOLOGICAL TYPES AND CLINICAL CHARACTERISTICS OF LUPUS NEPHRITIS PATIENTS AT RSUP DR. KARIADI SEMARANG
    Nugroho, Y. D.
    Nurani, A.
    Partiningrum, D. L.
    Arwanto, A.
    Lestariningsih, L.
    Chasani, S.
    NEPHROLOGY, 2021, 26 : 34 - 34
  • [36] Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy
    Park, MC
    Park, YB
    Jung, SY
    Chung, IH
    Choi, KH
    Lee, SK
    LUPUS, 2004, 13 (08) : 569 - 574
  • [37] PREDICTIVE VALUE OF RENAL BIOPSY IN PATIENTS WITH FOCAL AND DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS TREATED WITH INTRAVENOUS CYCLOPHOSPHAMIDE
    FISCHER, CA
    CONLON, PJ
    LEVESQUE, M
    HOWELL, DN
    LABORATORY INVESTIGATION, 1995, 72 (01) : A158 - A158
  • [38] Clinical outcome in 7 patients with idiopathic inflammatory myositis treated with rituximab
    Sultan, SM
    Isenberg, DA
    Cambridge, G
    Edwards, JCW
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S316 - S316
  • [39] Is azathioprine an alternative for cyclophosphamide in the treatment of patients with proliferative lupus nephritis? Two-year results of the Dutch lupus nephritis study I
    Grootscholten, C
    Bijl, M
    Ligtenberg, G
    Hagen, EC
    Bake, AWLVD
    de Glas-Vos, JW
    van Houwelingen, JC
    Derksen, RWHM
    Berden, JHM
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 112 - 112
  • [40] Rituximab plus cyclophosphamide in severe SLE: Results in 15 patients who failed conventional immunosuppressive therapy
    van Vollenhoven, RF
    Gunnarsson, I
    Welin-Henriksson, E
    Jonsdottir, T
    Sundelin, B
    Jacobsson, S
    Klareskog, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S741 - S741